Date published: 2026-5-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ctr9 Inhibitors

CTR9 inhibitors are related to the processes of transcription regulation and chromatin modification, which are areas where CTR9 is actively involved as part of the PAF1 complex. The PAF1 complex plays a crucial role in transcription elongation and chromatin modifications associated with active gene expression. Compounds listed here target various aspects of these processes, potentially influencing the function of CTR9. Histone deacetylase (HDAC) inhibitors like Trichostatin A, Suberoylanilide Hydroxamic Acid, RGFP966, Mocetinostat, and JNJ-26481585 modify chromatin structure by preventing the removal of acetyl groups from histones. This action leads to a more open chromatin state, which can impact gene expression regulation and potentially the function of CTR9 in transcription elongation. DNA methyltransferase inhibitors like 5-Azacytidine alter the DNA methylation landscape, which is another key aspect of chromatin structure affecting gene expression. Caffeine and Curcumin, though not specific inhibitors of transcriptional processes, are known to influence various cellular pathways, including those related to DNA repair and transcription, and could indirectly affect CTR9's role. JQ1 and I-BET target the BET family of bromodomain-containing proteins, which are important in regulating gene expression by modulating chromatin structure. GSK343, an inhibitor of EZH2, affects the Polycomb repressive complex 2 (PRC2), which is involved in histone methylation, another key aspect of chromatin modification impacting transcription. These inhibitors are valuable tools for understanding the complex mechanisms of transcription regulation and chromatin modification. They offer insights into how transcription is modulated at the chromatin level and the potential role of components like CTR9 in these processes. While these compounds do not target CTR9 directly, their effects on transcriptional regulation and chromatin states can provide indirect information about the functional role of CTR9 in gene expression. Studying these inhibitors helps in dissecting the intricate balance of transcriptional activation and repression, which is crucial for proper cellular function and development.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Another HDAC inhibitor, which can affect chromatin remodeling and potentially CTR9's role in transcription.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Known to affect multiple cellular processes, including DNA repair and transcription, potentially influencing CTR9 function.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

A natural compound that can modulate various signaling pathways and potentially affect transcriptional regulation involving CTR9.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

A bromodomain inhibitor, it affects transcription by inhibiting BET proteins, potentially influencing CTR9 activity.

RGFP966

1357389-11-7sc-507300
5 mg
$115.00
(0)

An HDAC3-specific inhibitor, potentially impacting chromatin remodeling and CTR9 function.

GSK343

1346704-33-3sc-397025
sc-397025A
5 mg
25 mg
$151.00
$461.00
1
(0)

An inhibitor of EZH2, a component of the PRC2 complex, potentially affecting chromatin states and CTR9 activity.

Mocetinostat

726169-73-9sc-364539
sc-364539B
sc-364539A
5 mg
10 mg
50 mg
$214.00
$247.00
$1463.00
2
(1)

An HDAC inhibitor, can affect gene expression regulation and potentially impact CTR9 function.

JNJ-26481585

875320-29-9sc-364515
sc-364515A
5 mg
50 mg
$321.00
$1224.00
(1)

A potent HDAC inhibitor, potentially affecting chromatin structure and CTR9-mediated transcription regulation.